Therapies
Products
BrainCool
RhinoChill
Cooral
Products
BrainCool
RhinoChill
Cooral
Studies
Published Studies
Ongoing Studies
Investor Relations
Rights Issue
Financial Calendar
Financial Reports
Annual General Meeting
Presentations
Press Releases
Articles of Association
Certified Advisor
The Share
About Us
BrainCool AB
Management
Board of Directors
Organisation
Contact
Contact
Ongoing Studies
Our ongoing clinical trials
Clinical Trial in Cardiac Arrest (PRINCESS2)
PRINCESS2 Trial:
- 8 European countries
- 920 patients
- Expected start date: 2023
- Primary outcome: Survival with complete neurologic recovery at 90 days (mRS0-1)
PRINCESS2 Trial Website
Clinical Trial in Stroke (COTTIS2)
COTTIS2 Trial:
- 5 sites in Germany
- >400 patients
- Expected start date: September 2023
- Primary outcome: Improvement of neurological outcome measured by mRS at day 90 after stroke
COTTIS2 Trial Website
Our Products
BrainCool
RhinoChill
Cooral
